Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Statement re Offer for Subscription

26 Sep 2018 18:29

RNS Number : 0755C
Maven Income & Growth VCT PLC
26 September 2018
 

Joint Announcement

 

Offer for Subscription

26 September 2018

The Board of Directors of Maven Income and Growth VCT PLC ("Maven VCT 1") and Maven Income and Growth VCT 5 PLC ("Maven VCT 5") (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in each of the Companies to raise, in aggregate, up to £30 million with over-allotment facilities of up to, in aggregate, a further £10 million (before issue costs) (the "Offers").

 

The Companies have also published a joint Circular (the "Circular") seeking the approval of their respective Shareholders for matters in connection with the Offers, each Company giving notice of a General Meeting to be held on 2 November 2018 (the "General Meeting").

 

The Offers will open on 26 September 2018 and the deadline for receipt of applications is 12.00 noon on 3 April 2019 in relation to the tax year 2018/19 and 12.00 noon on 26 April 2019 in relation to the tax year 2019/20. The Offers will close on 26 April 2019 unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant Board to no later than 16 September 2019. Each Company intends to re-introduce its dividend investment scheme (DIS) with immediate effect. Applicants under the Offers can make a DIS election using the application form for the Offers. Full details of each Company's DIS, together with mandate forms are available from the relevant Company's website.

 

Each Offer is conditional on the passing of all the resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 26 September 2018 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of the Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the fee applying in certain cases (for instance, early applications under the Offers). Maven as the investment manager of each Company is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Maven VCT 1 has also agreed with Maven, subject to Shareholder approval on the terms set out in the Circular, to vary the terms of a management and administration deed entered into with Maven on 1 March 2015 (the "Deed"), with the effect that, from 1 March 2019, Maven's fee for secretarial services will increase from £50,000 to £100,000 per annum (excluding VAT, if any), the notice period under the Deed will be increased from six months to twelve months, and the cap on fees payable to Maven under the Deed will be removed. As Maven is a related party of Maven VCT 1 under the Listing Rules, the aggregate potential impact of the above changes to the terms of the management and administration deed between that Company and Maven is a transaction to which Listing Rule 11.1.10R applies.

The Maven VCT 1 Board composition is regularly reviewed by the Directors, and Fiona Wollocombe will step down from the Board at the end of the current financial year. Maven VCT 1 Shareholders will be informed when further information is available regarding the appointment of replacement or additional Directors.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven Capital Partners LLP on 0141 306 7400. A downloadable version of the Securities Note will also be available from each of the Company's websites: http://www.mavencp.com/migvct and http://mavencp.com/migvct5.

Copies of the Prospectus and Circular are available, free of charge, from Maven Capital Partners UK LLP at Kintyre House, 205 West George Street, Glasgow G2 2LW.

 

In accordance with the Listing Rules, the Prospectus and Circular have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Any enquiries in respect of the Offers should be directed to:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400E-mail: enquiries@mavencp.com 

 

Maven Capital Partners UK LLPSecretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRDQLFLVKFBBBV
Date   Source Headline
6th Apr 202112:50 pmRNSDirector/PDMR Shareholding
6th Apr 20217:00 amRNSIssue of Equity
24th Mar 20215:56 pmRNSStatement re Offer for Subscription
23rd Mar 20213:41 pmRNSPublication of Suppl.Prospcts
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSIssue of Equity
8th Feb 20219:56 amRNSStatement re Offer for Subscription
4th Feb 20215:10 pmRNSTransaction in Own Shares
29th Jan 20214:42 pmRNSTransaction in Own Shares
28th Jan 20214:40 pmRNSStatement re Offer for Subscription
22nd Jan 20213:13 pmRNSNet Asset Value(s)
27th Nov 202010:41 amRNSResult of General Meeting
20th Nov 20205:18 pmRNSIssue of Equity
16th Nov 20204:53 pmRNSTransaction in Own Shares
13th Nov 20203:43 pmRNSStatement re Dividend Investment Scheme
26th Oct 20207:00 amRNSPublication of a Prospectus
19th Oct 20204:43 pmRNSHalf-year Report
15th Oct 20204:45 pmRNSStatement re NAV and Interim Dividend
26th Aug 20205:19 pmRNSTransaction in Own Shares
29th Jul 20204:42 pmRNSTransaction in Own Shares
28th Jul 20204:48 pmRNSTransaction in Own Shares
22nd Jul 20203:12 pmRNSNet Asset Value(s)
22nd Jul 20202:25 pmRNSStatement re Intended Joint Offersfor Subscription
22nd Jul 202012:18 pmRNSResult of AGM
29th May 202011:37 amRNSAnnual Financial Report
26th May 20204:54 pmRNSTransaction in Own Shares
27th Apr 20204:19 pmRNSTransaction in Own Shares
21st Apr 20205:17 pmRNSNet Asset Value & Final Dividend
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSSuspension of Dividend Investment Scheme
19th Mar 20201:48 pmRNSDirector Declaration
23rd Jan 20203:36 pmRNSNet Asset Value(s)
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
28th Nov 20195:06 pmRNSTransaction in Own Shares
22nd Nov 20193:31 pmRNSDirector/PDMR Shareholding
22nd Nov 20192:45 pmRNSIssue of Equity
20th Nov 20194:44 pmRNSStatement re Dividend Investment Scheme
31st Oct 20194:42 pmRNSHalf-year Report
15th Oct 20192:33 pmRNSTransaction in Own Shares
15th Oct 20199:56 amRNSStatement re Net Asset Value and Interim Dividend
31st Jul 20193:37 pmRNSTransaction in Own Shares
4th Jul 20191:08 pmRNSNet Asset Value(s)
4th Jul 201912:55 pmRNSResult of AGM
24th May 20193:09 pmRNSAnnual Financial Report
20th May 20194:34 pmRNSTransaction in Own Shares
20th May 201911:29 amRNSTransaction in Own Shares
24th Apr 20199:47 amRNSIssue of Equity
5th Apr 20194:42 pmRNSHolding(s) in Company
8th Mar 20192:30 pmRNSDirector/PDMR Shareholding
8th Mar 20192:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.